Corporate Banner
Satellite Banner
Biomolecular Screening
Scientific Community
 
Become a Member | Sign in
Home>Events>This Event
  Events - September 2014


Enabling Genomic Technologies and Screening Asia 2014

11 Sep 2014 - 12 Sep 2014 - Matrix@Biopolis, Singapore, Singapore



Bookmark and Share


Select Biosciences South East Asia has announced that our Enabling Genomic Technologies and Screening Asia Conference and Exhibition will take place at the Biopolis, Singapore on the 11th and 12th September 2014.

We are co-hosting the event with The Genome Institute of Singapore (GIS) at A*STAR’s conference facilities within the Biopolis, the Biomedical Science hub for Singapore.

The event will have two concurrent conference tracks, with presentations from the leading scientists within these fields. The first conference track will cover Enabling Genomic Technologies and we are proud to welcome Dr. Kosuke Yusa as our Keynote Speaker for the meeting. Dr. Kosuke Yusa is a member of the Sanger Institute Faculty, UK.

We are also pleased to welcome both Dr. Ramanuj DasGupta, Group Leader/Senior Investigator, GIS, Cancer Therapeutics & Stratified Oncology, Assoc. Professor, NYU Cancer Institute and Dr. Pauline Ng, Group Leader/Senior Investigator, GIS, Chief Informatics Officer, Polaris. They will be representing our partner, The Genome Institute Singapore (GIS).

The second track is entitled Screening Asia and we are privileged to have Dr. Alex Matter, M.D., Professor David Virshup and Dr. Litao Zhang, as our Keynote Speakers.

Dr. Matter is the CEO of the Experimental Therapeutics Centre, A*STAR, Singapore. Professor Virshup is the inaugural Director of the Cancer and Stem Cell Biology Program at the Duke-NUS Graduate Medical School in Singapore. Dr Litao Zhang is the Vice President of Leads Discovery and Optimization, Bristol-Myers Squibb.

Attending this meeting will give you an opportunity for networking with like-minded peers, helping you to find unique solutions and build long term collaborations. With all delegates having full access to both conference tracks, everyone has the opportunity to develop the specific agenda of their choice.



Further information
Scientific News
Platelets are the Pathfinders for Leukocyte Extravasation During Inflammation
Findings from the study could help in the prevention and treatment of inflammatory pathologies.
Benchtop Automation Trends
Gain a better understanding of current interest in and future deployment of benchtop automated systems.
Penn State, TB Alliance, and GSK Partner To Discover New Treatments For TB
A new collaboration between TB Alliance, GSK, and scientists in the Eberly College of Science seeks to find new small molecules that can be used to create antibiotics in the fight against tuberculosis (TB).
Molecular Map Provides Clues To Zinc-Related Diseases
Mapping the molecular structure where medicine goes to work is a crucial step toward drug discovery against deadly diseases.
Genetic Research Can Significantly Improve Drug Development
With drug development costs topping $1.2bn (£850 million) to get a single treatment to the point it can be sold and used in the clinic, could genetic analysis save hundreds of millions of dollars?
New Method Opens Door to Development of Many New Medicines
Findings from TSRI reveal human proteins are better drug targets than previously thought.
Diagnosing Systemic Infections Quickly, Reliably
Team develop rapid and specific diagnostic assay that could help physicians decide within an hour whether a patient has a systemic infection and should be hospitalized for aggressive intervention therapy.
What Makes a Good Scientist?
It’s the journey, not just the destination that counts as a scientist when conducting research.
Blood Test That Detects Early Alzheimer’s Disease
A research team, led by Dr. Robert Nagele from Rowan University School of Osteopathic Medicine and Durin Technologies, Inc., has announced the development of a blood test that leverages the body’s immune response system to detect an early stage of Alzheimer’s disease – referred to as the mild cognitive impairment (MCI) stage – with unparalleled accuracy.
A New Approach to Chemical Synthesis
Communesins, originally found in fungus, could hold potential as cancer drugs.
Scroll Up
Scroll Down
SELECTBIO

SELECTBIO Market Reports
Go to LabTube
Go to eposters
 
Access to the latest scientific news
Exclusive articles
Upload and share your posters on ePosters
Latest presentations and webinars
View a library of 1,800+ scientific and medical posters
3,200+ scientific and medical posters
A library of 2,500+ scientific videos on LabTube
4,700+ scientific videos
Close
Premium CrownJOIN TECHNOLOGY NETWORKS PREMIUM FOR FREE!